Author Archives: John E. Fitzgibbon Jr.

March’s IPO calendar makes its debut this week with one, two or three deals, depending upon your interpretation of the fine print on the cover page of the prospectus.  Two of the three have notations alerting potential investors of a deviation from normal underwriting procedures.  The Best Effort Wowo Ltd. (WOWO – proposed) is a […]

Five names are on the IPO calendar this week, when Friday will mark the first day of spring. Two of these deals are best described in Wall Street jargon: One is a “BDC” and the other is an offering on a “best efforts” basis. And Alibaba Group Holdings (BABA) returns to the spotlight. Its IPO […]

As the NASDAQ Composite Index reaches for 5,000, a level it has not seen in 15 years, the question arises: “Where are the IPOs?” Last week’s calendar produced two small deals. This week has none. However, there are indications that a favored industrial sector from yesteryear is awaiting in the wings to make a comeback. […]

IPOs take a holiday this week. Even though there are four deals on this week’s calendar, most are carryovers from the past listed as “day to day.” What we are seeing is a transitional period as the biotech/healthcare sector is playing out, but there are clues that the IPO market may have found new leadership. […]

If you were standing at the corner of Broad and Wall Street last week, you might have felt a shift in the winds swirling around the IPO calendar. Technology was edging in, easing health care aside. When the IPO curtain rose on Monday, Feb. 2, the calendar had nine health-care issues looking to make their […]

January’s IPO market ended with fireworks. The final Friday of the month produced two opening-day moonshots. February opens with a dozen IPOs, mostly from the health-care sector – a sector that has become selective. Friday provided an example. A moonshot, friends, is easy to recognize: By the closing bell on its first day of trading, […]